[Perthoracal local therapy of cavernous silicotuberculosis].
D000995:Antitubercular Agents / Q000008:administration & dosage*; D003523:Cycloserine / Q000008:administration & dosage / Q000627:therapeutic use; D004781:Environmental Exposure; D005260:Female; D006469:Hemoptysis / Q000209:etiology; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011677:Punctures; D012830:Silicotuberculosis / Q000175:diagnosis / Q000188:drug therapy*; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin; D013909:Thorax
D000995:Antitubercular Agents; D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin
Die perthorakale Lokalbehandlung der kavernisierenden Silikotuberkulose.